Very keen to see what Dr Bruder achieves with Regeneus.
Some nice information in this quarterly, particularly the desire to fund the coy without share dilution. Beautiful. 2022 looks like tis going to be a good one for RGS.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CMB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.772M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1900 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 14500 | 1 |
View Market Depth
| Last trade - 16.12pm 16/07/2024 (20 minute delay) ? |
| CMB (ASX) Chart |
Day chart unavailable